Back to mobile site

BofA Securities on Medtronic, Inc. (MDT): 'one of few accelerating growth companies in medtech'

March 23, 2026 8:44 AM EDT Send to a Friend
BofA Securities analyst Travis Steed reiterated a Buy rating and $110.00 price target on Medtronic, Inc. (NYSE: MDT)The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login